rs2277869
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000540885.1(WNK1):n.25T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.16 in 1,360,380 control chromosomes in the GnomAD database, including 17,777 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 1886 hom., cov: 32)
Exomes 𝑓: 0.16 ( 15891 hom. )
Consequence
WNK1
ENST00000540885.1 non_coding_transcript_exon
ENST00000540885.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.237
Publications
18 publications found
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
- neuropathy, hereditary sensory and autonomic, type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
- pseudohypoaldosteronism type 2CInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 12-907744-T-C is Benign according to our data. Variant chr12-907744-T-C is described in ClinVar as Benign. ClinVar VariationId is 1229228.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| WNK1 | ENST00000340908.9 | c.7400-103T>C | intron_variant | Intron 26 of 27 | 5 | NM_213655.5 | ENSP00000341292.5 | |||
| WNK1 | ENST00000315939.11 | c.6644-103T>C | intron_variant | Intron 26 of 27 | 1 | NM_018979.4 | ENSP00000313059.6 |
Frequencies
GnomAD3 genomes AF: 0.158 AC: 23972AN: 152130Hom.: 1881 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
23972
AN:
152130
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.160 AC: 193302AN: 1208132Hom.: 15891 Cov.: 17 AF XY: 0.161 AC XY: 98630AN XY: 613550 show subpopulations
GnomAD4 exome
AF:
AC:
193302
AN:
1208132
Hom.:
Cov.:
17
AF XY:
AC XY:
98630
AN XY:
613550
show subpopulations
African (AFR)
AF:
AC:
4859
AN:
28326
American (AMR)
AF:
AC:
9440
AN:
44360
Ashkenazi Jewish (ASJ)
AF:
AC:
3579
AN:
24606
East Asian (EAS)
AF:
AC:
4382
AN:
38536
South Asian (SAS)
AF:
AC:
15701
AN:
80494
European-Finnish (FIN)
AF:
AC:
5805
AN:
51562
Middle Eastern (MID)
AF:
AC:
667
AN:
3676
European-Non Finnish (NFE)
AF:
AC:
140662
AN:
884718
Other (OTH)
AF:
AC:
8207
AN:
51854
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8685
17370
26056
34741
43426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4602
9204
13806
18408
23010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.158 AC: 24002AN: 152248Hom.: 1886 Cov.: 32 AF XY: 0.156 AC XY: 11597AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
24002
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
11597
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
6863
AN:
41546
American (AMR)
AF:
AC:
3031
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
488
AN:
3472
East Asian (EAS)
AF:
AC:
484
AN:
5176
South Asian (SAS)
AF:
AC:
886
AN:
4832
European-Finnish (FIN)
AF:
AC:
1175
AN:
10606
Middle Eastern (MID)
AF:
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10536
AN:
68006
Other (OTH)
AF:
AC:
341
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1067
2134
3200
4267
5334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
505
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.